FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Baxter Healthcare Famotidine Injection 20 mg Recall

Famotidine Injection 20 mg, Rx Only, GALAXY Single Dose Container, Code 2G3424, Sterile…

Baxter Healthcare Corp. · Deerfield, IL

Risk level
Class II
Reported by FDA
Dec 17, 2014
Recall ID
D-0293-2015
Check your lot numberHow we source this data

Summary

Baxter Healthcare recalled Famotidine Injection 20 mg starting Apr 24, 2014. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0293-2015 on Dec 17, 2014. Reason: Presence of Particulate Matter: Baxter Healthcare Corporation has received a complaint reporting the presence of particulate matter identified as plastic/rubber in famotidine Injection premixed containers. Status: Terminated.

Why it was recalled

Presence of Particulate Matter: Baxter Healthcare Corporation has received a complaint reporting the presence of particulate matter identified as plastic/rubber in famotidine Injection premixed containers.

Product description

Famotidine Injection 20 mg, Rx Only, GALAXY Single Dose Container, Code 2G3424, Sterile Nonpyrogenic, 50 mL Iso-osmotic, Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-5197-41.

Lot numbers, UPCs & expiration codes

Lot #: NC082768, Exp 12/23/2014

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0293-2015
Classification
Class II
Status
Terminated
Recall initiated
Apr 24, 2014
FDA report date
Dec 17, 2014
Quantity
19,152 Containers
Recall type
Voluntary: Firm initiated
Recalling firm
Baxter Healthcare Corp.

Original FDA data

Every field from FDA enforcement report D-0293-2015, exactly as published.

Show all FDA fields
City
Deerfield
State
IL
Status
Terminated
Country
United States
Event ID
68171
Address
1 Baxter Pkwy
Code information
Lot #: NC082768, Exp 12/23/2014
Postal code
60015-4625
Report date
Dec 17, 2014
Product type
Drugs
Recall number
D-0293-2015
Classification
Class II
Recalling firm
Baxter Healthcare Corp.
Product quantity
19,152 Containers
Termination date
Jun 16, 2015
Reason for recall
Presence of Particulate Matter: Baxter Healthcare Corporation has received a complaint reporting the presence of particulate matter identified as plastic/rubber in famotidine Injection premixed containers.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Famotidine Injection 20 mg, Rx Only, GALAXY Single Dose Container, Code 2G3424, Sterile Nonpyrogenic, 50 mL Iso-osmotic, Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-5197-41.
Distribution pattern
Nationwide
Recall initiation date
Apr 24, 2014
Initial firm notification
Letter
Center classification date
Dec 10, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0293-2015, published Dec 17, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls